169 related articles for article (PubMed ID: 25986311)
21. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
[TBL] [Abstract][Full Text] [Related]
22. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
23. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer.
Lipkin SM; Rozek LS; Rennert G; Yang W; Chen PC; Hacia J; Hunt N; Shin B; Fodor S; Kokoris M; Greenson JK; Fearon E; Lynch H; Collins F; Gruber SB
Nat Genet; 2004 Jul; 36(7):694-9. PubMed ID: 15184898
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.
Poynter JN; Siegmund KD; Weisenberger DJ; Long TI; Thibodeau SN; Lindor N; Young J; Jenkins MA; Hopper JL; Baron JA; Buchanan D; Casey G; Levine AJ; Le Marchand L; Gallinger S; Bapat B; Potter JD; Newcomb PA; Haile RW; Laird PW;
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3208-15. PubMed ID: 18990764
[TBL] [Abstract][Full Text] [Related]
25. MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.
Sidelnikov E; Bostick RM; Flanders WD; Long Q; Cohen VL; Dash C; Seabrook ME; Fedirko V
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1599-609. PubMed ID: 19423536
[TBL] [Abstract][Full Text] [Related]
26. Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Hubner RA; Houlston RS
J Natl Cancer Inst; 2007 Oct; 99(19):1490; author reply 1490-1. PubMed ID: 17895478
[No Abstract] [Full Text] [Related]
27. [Association of MLH1 gene 415G/C polymorphism with colorectal cancer in Chinese].
Tao WP; Hu S; Feng JP; Xie YS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):314-7. PubMed ID: 19504447
[TBL] [Abstract][Full Text] [Related]
28. Validation microsatellite path score in a population-based cohort of patients with colorectal cancer.
Bessa X; Alenda C; Paya A; Álvarez C; Iglesias M; Seoane A; Dedeu JM; Abulí A; Ilzarbe L; Navarro G; Pellise M; Balaguer F; Castellvi-Bel S; Llor X; Castells A; Jover R; Andreu M
J Clin Oncol; 2011 Sep; 29(25):3374-80. PubMed ID: 21788563
[TBL] [Abstract][Full Text] [Related]
29. Multivariate analysis as a method for evaluating the pathogenicity of novel genetic MLH1 variants in patients with colorectal cancer and microsatellite instability.
Duraturo F; Liccardo R; Cavallo A; De Rosa M; Rossi GB; Izzo P
Int J Mol Med; 2015 Aug; 36(2):511-7. PubMed ID: 26096739
[TBL] [Abstract][Full Text] [Related]
30. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.
Jenkins MA; Dowty JG; Ait Ouakrim D; Mathews JD; Hopper JL; Drouet Y; Lasset C; Bonadona V; Win AK
J Clin Oncol; 2015 Feb; 33(4):326-31. PubMed ID: 25534380
[TBL] [Abstract][Full Text] [Related]
31. Relevance of hMLH1 -93G>A, 655A>G and 1151T>A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies.
Zare M; Jafari-Nedooshan J; Jafari M; Neamatzadeh H; Abolbaghaei SM; Foroughi E; Nasiri R; Zare-Shehneh M
Rev Assoc Med Bras (1992); 2018 Oct; 64(10):942-951. PubMed ID: 30517243
[TBL] [Abstract][Full Text] [Related]
32. Mismatch repair polymorphisms and the risk of colorectal cancer.
Berndt SI; Platz EA; Fallin MD; Thuita LW; Hoffman SC; Helzlsouer KJ
Int J Cancer; 2007 Apr; 120(7):1548-54. PubMed ID: 17205513
[TBL] [Abstract][Full Text] [Related]
33. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
34. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer.
Martínez-Urueña N; Macías L; Pérez-Cabornero L; Infante M; Lastra E; Cruz JJ; Miner C; González R; Durán M
Colorectal Dis; 2013 Mar; 15(3):e118-23. PubMed ID: 23374646
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer.
Yan ZH; Cui LH; Wang XH; Li C; He X
World J Gastroenterol; 2014 Dec; 20(48):18338-45. PubMed ID: 25561800
[TBL] [Abstract][Full Text] [Related]
36. Effect of MLH1 -93G>A on gene expression in patients with colorectal cancer.
Funck A; Santos JC; Silva-Fernandes IJ; Rabenhorst SH; Martinez CA; Ribeiro ML
Med Oncol; 2014 Sep; 31(9):160. PubMed ID: 25115745
[TBL] [Abstract][Full Text] [Related]
37. A meta-analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorectal cancer.
Zhang R; Qin W; Xu GL; Zeng FF; Li CX
Colorectal Dis; 2012 Mar; 14(3):e80-9. PubMed ID: 21988782
[TBL] [Abstract][Full Text] [Related]
38. Common genetic variants (rs4779584 and rs10318) at 15q13.3 contributes to colorectal adenoma and colorectal cancer susceptibility: evidence based on 22 studies.
Tu L; Yan B; Peng Z
Mol Genet Genomics; 2015 Jun; 290(3):901-12. PubMed ID: 25475391
[TBL] [Abstract][Full Text] [Related]
39. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
40. Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity.
Perera S; Mrkonjic M; Rawson JB; Bapat B
Oncol Rep; 2011 Mar; 25(3):809-15. PubMed ID: 21206982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
